Breaking News Instant updates and real-time market news.

T

AT&T

$42.42

-0.19 (-0.45%)

, TWX

Time Warner

$98.28

-0.28 (-0.28%)

16:44
03/20/17
03/20
16:44
03/20/17
16:44

AT&T offers DIRECTV NOW customers one year of HBO

AT&T (T) announced that new customers who subscribe to its DIRECTV NOW "Go Big" or "Gotta Have It" packages will have Time Warner's (TWX) HBO included in their service for a year. "To sweeten the deal, new customers can still sign up for 3 months of pre-paid service on any DIRECTV NOW package and get an Apple (AAPL) TV included. Both offers end March 30," the company noted. Reference Link

T

AT&T

$42.42

-0.19 (-0.45%)

TWX

Time Warner

$98.28

-0.28 (-0.28%)

AAPL

Apple

$141.45

1.46 (1.04%)

  • 09

    May

T AT&T
$42.42

-0.19 (-0.45%)

03/08/17
WELS
03/08/17
NO CHANGE
WELS
Tower sector upgraded to Overweight at Wells Fargo
Wells Fargo analyst Jennifer Fritzsche upgraded the Tower sector to Overweight from Market Weight saying it is time to get off the sidelines. Tower companies are positioned to benefit from additional spend from AT&T (T) related to FirstNet, Fritzsche tells investors in a research note. In conjunction with the sector, the analyst upgraded Crown Castle (CCI) to Outperform from Market Perform, and calls the stock her new top pick in the space. The analyst also has an Outperform rating on Uniti Group (UNIT).
03/02/17
LOOP
03/02/17
DOWNGRADE
Target $107.5
LOOP
Hold
Time Warner downgraded to Hold from Buy at Loop Capital
Loop Capital analyst David Miller downgraded Time Warner (TWX) to Hold saying the AT&T (T) deal spread is "finally thinning." The analyst keeps a $107.50 price target for the shares.
03/06/17
UBSW
03/06/17
DOWNGRADE
Target $108
UBSW
Neutral
Time Warner downgraded to Neutral from Buy at UBS
UBS analyst Doug Mitchelson downgraded Time Warner (TWX) to Neutral citing limited upside potential given the terms of the AT&T (T) offer. Time Warner shares now trade at a less than 10% spread to the AT&T offer value, the analyst notes. He keeps a $108 price target for the shares.
03/08/17
WELS
03/08/17
UPGRADE
WELS
Outperform
Crown Castle upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Jennifer Fritzsche upgraded Crown Castle (CCI) to Outperform saying the company is poised to benefit from an increase in carrier activity before the other public tower companies given its large exposure to AT&T (T) and domestic focus. The analyst raised her price target range for the shares to $110-$115 from $98-$100 and calls Crown Castle her top pick in the towers group.
TWX Time Warner
$98.28

-0.28 (-0.28%)

01/30/17
OPCO
01/30/17
NO CHANGE
Target $82
OPCO
Outperform
Comcast price target raised to $82 from $74 at Oppenheimer
Oppenheimer analyst Timothy Horan raised his price target for Comcast (CMCSA) to $82 from $74 on valuation after the company reported a "strong" Q4. The analyst sees Comcast's vertically integrated model as well positioned, and believes management will continue to meet the OTT/Wireless challenges. Additionally, Horan sees the company acquisition of T-Mobile (TMUS) as "very likely," noting that Comcast's results do "provide logic" behind AT&T (T)/Time Warner (TWX) and a Verizon (VZ)/Charter (CHTR)/content merger. He reiterates an Outperform rating on Comcast's shares.
02/01/17
MOFT
02/01/17
DOWNGRADE
MOFT
Neutral
Time Warner downgraded to Neutral from Buy at MoffettNathanson
AAPL Apple
$141.45

1.46 (1.04%)

03/20/17
ARGS
03/20/17
NO CHANGE
ARGS
Apple has positive read through from Jabil results, says Argus
Argus analyst Jim Kelleher believes that Jabil (JBL) reported "solid" results which bode well for Apple (AAPL). However, the analyst says that Jabil has been disappointing after triggering elevated expectations in the past, and he keeps a Hold rating on that stock.
03/20/17
COWN
03/20/17
NO CHANGE
Target $155
COWN
Outperform
Apple price target raised to $155 from $135 at Cowen
Cowen analyst Timothy Arcuri raised his price target on Apple to $155 from $135 as he believes Street estimates remain way too low. He sees an aging iPhone base, especially in China, that should lead to a powerful launch of the iPhone 8. In addition to Street estimates having to come up, Arcuri also sees the potential for additional multiple expansion. Arcuri reiterated his Outperform rating on Apple shares.
03/20/17
RBCM
03/20/17
NO CHANGE
RBCM
iPhone 8 could match or surpass iPhone 6, says RBC Capital
RBC Capital analyst Amit Daryanani believes that the unit sales and growth of iPhone 8, due out in September, "could match or even surpass" the performance of the iPhone 6. The analyst expects the iPhone 8 to feature wireless charging and an improved processor., as well as "a complete redesign." He believes that the redesign can cause Apple's share gains to accelerate, enabling the growth of its services business to increase. Daryanani keeps a $155 price target and an Outperform rating on the shares.
03/20/17
PIPR
03/20/17
NO CHANGE
Target $155
PIPR
Overweight
Piper analysis yields $163 current fair value for Apple shares
Piper Jaffray analyst Michael Olson expects Apple's services revenue to rise from an 11% contribution in FY16 to 17% in FY20. As services approaches 20% of revenue, with a larger contribution to profitability due to higher margin relative to the core business, many investors will shift to a sum-of-the-parts valuation on Apple, Olson tells investors in a research note. His sum-of-the-parts analysis looking out two years values Apple at $195 per share. Discounting that back two years, the analyst comes up with a current fair value of $163 per share. Apple closed Friday down 78c to $139.91. Olson remains a buyer of Apple citing the "growing anticipation" around the iPhone 8 and a "strong trajectory" for services revenue. He maintains an Overweight rating on the shares with a $155 price target.

TODAY'S FREE FLY STORIES

06:05
05/29/17
05/29
06:05
05/29/17
06:05
General news
WTI crude futures are off by 0.2% »

WTI crude futures are off…

03:10
05/29/17
05/29
03:10
05/29/17
03:10
General news
FX Update: The dollar majors have been plying narrow ranges »

FX Update: The dollar…

03:05
05/29/17
05/29
03:05
05/29/17
03:05
General news
Fed's Williams: three hikes this year still make sense. »

Fed's Williams:…

RBGLY

Reckitt Benckiser

$20.53

0.04 (0.20%)

, MJN

Mead Johnson

$89.29

0.1 (0.11%)

15:32
05/28/17
05/28
15:32
05/28/17
15:32
Conference/Events
Mead Johnson to host special shareholder meeting »

Special Shareholder…

RBGLY

Reckitt Benckiser

$20.53

0.04 (0.20%)

MJN

Mead Johnson

$89.29

0.1 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

PHH

PHH Corp.

$13.58

0.06 (0.44%)

15:25
05/28/17
05/28
15:25
05/28/17
15:25
Conference/Events
PHH Corp. to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

TPIV

TapImmune

$3.71

-0.03 (-0.80%)

14:37
05/28/17
05/28
14:37
05/28/17
14:37
Conference/Events
TapImmune to hold a business update conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

SCOR

comScore

$24.80

-0.15 (-0.60%)

14:35
05/28/17
05/28
14:35
05/28/17
14:35
Conference/Events
comScore to host business news update conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

BMY

Bristol-Myers

$53.97

-0.42 (-0.77%)

14:12
05/28/17
05/28
14:12
05/28/17
14:12
Conference/Events
Bristol-Myers to hold a pharmaceutical update conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 04

    Jun

  • 06

    Jun

  • 24

    Sep

LOXO

Loxo Oncology

$47.44

-0.06 (-0.13%)

14:10
05/28/17
05/28
14:10
05/28/17
14:10
Conference/Events
Loxo Oncology to hold a pharmaceutical update conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 04

    Jun

  • 06

    Jun

ADRO

Aduro Biotech

$10.05

-0.15 (-1.47%)

14:07
05/28/17
05/28
14:07
05/28/17
14:07
Conference/Events
Aduro Biotech to host analyst and investor meeting »

Management hosts special…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

ELGX

Endologix

$4.73

-0.05 (-1.05%)

14:06
05/28/17
05/28
14:06
05/28/17
14:06
Conference/Events
Endologix to hold a pharmaceutical update conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 31

    May

  • 03

    Jun

TSRO

Tesaro

$149.11

-4.08 (-2.66%)

14:02
05/28/17
05/28
14:02
05/28/17
14:02
Conference/Events
Tesaro to hold an analyst and investor briefing »

Management hosts an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 03

    Jun

  • 30

    Jun

ICE

IntercontinentalExchange

$60.35

-0.09 (-0.15%)

13:57
05/28/17
05/28
13:57
05/28/17
13:57
Conference/Events
IntercontinentalExchange to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 07

    Jun

CPA

Copa Holdings

$111.69

0.2 (0.18%)

13:48
05/28/17
05/28
13:48
05/28/17
13:48
Conference/Events
Copa Holdings to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

CAH

Cardinal Health

$73.10

-0.34 (-0.46%)

13:31
05/28/17
05/28
13:31
05/28/17
13:31
Conference/Events
Cardinal Health to hold a meeting »

Dublin Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

BPMX

BioPharmX

$0.64

0.0089 (1.41%)

13:26
05/28/17
05/28
13:26
05/28/17
13:26
Conference/Events
BioPharmX holds state of acne symposium »

Management provides…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$80.63

-0.72 (-0.89%)

13:20
05/28/17
05/28
13:20
05/28/17
13:20
Conference/Events
Novartis to hold a meeting »

Meet the Management Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 26

    Jun

CNC

Centene

$74.57

-0.68 (-0.90%)

, MOH

Molina Healthcare

$66.87

-0.21 (-0.31%)

12:34
05/27/17
05/27
12:34
05/27/17
12:34
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

CNC

Centene

$74.57

-0.68 (-0.90%)

MOH

Molina Healthcare

$66.87

-0.21 (-0.31%)

HUM

Humana

$232.25

0.02 (0.01%)

AET

Aetna

$145.57

0.34 (0.23%)

ANTM

Anthem

$183.08

1.58 (0.87%)

UNH

UnitedHealth

$177.50

-0.55 (-0.31%)

WCG

WellCare

$172.97

0.15 (0.09%)

CI

Cigna

$161.32

-0.33 (-0.20%)

BX

Blackstone

$32.58

0.11 (0.34%)

NUE

Nucor

$58.15

-0.22 (-0.38%)

X

U.S. Steel

$19.74

-0.51 (-2.52%)

STLD

Steel Dynamics

$33.71

-0.73 (-2.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 13

    Jun

  • 16

    Jun

21:00
05/26/17
05/26
21:00
05/26/17
21:00
General news
Breaking General news story  »

San Francisco Federal…

20:00
05/26/17
05/26
20:00
05/26/17
20:00
General news
Breaking General news story  »

San Francisco Federal…

JUNO

Juno Therapeutics

$23.30

-2.22 (-8.70%)

18:11
05/26/17
05/26
18:11
05/26/17
18:11
Hot Stocks
Juno Therapeutics director acquires 20,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

UNH

UnitedHealth

$177.50

-0.55 (-0.31%)

18:06
05/26/17
05/26
18:06
05/26/17
18:06
Hot Stocks
UnitedHealth's OptumHealth awarded $200.5M government contract »

UnitedHealth's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

VEC

Vectrus

$29.62

0.02 (0.07%)

17:56
05/26/17
05/26
17:56
05/26/17
17:56
Hot Stocks
Vectrus Systems awarded $212.03M modification to government contract »

Vectrus Systems was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMMY

Imprimis

$3.34

-0.06 (-1.76%)

17:52
05/26/17
05/26
17:52
05/26/17
17:52
Syndicate
Breaking Syndicate news story on Imprimis »

Imprimis files $75M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRCP

IRSA Propiedades Comerciales

$43.58

-0.33 (-0.75%)

17:51
05/26/17
05/26
17:51
05/26/17
17:51
Syndicate
Breaking Syndicate news story on IRSA Propiedades Comerciales »

IRSA Propiedades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.